M&A decisions are among the most consequential — and irreversible — choices an organisation makes. Yet they are routinely made with incomplete market intelligence.
From surface-level target profiles to overstated synergy assumptions, we provide the deep intelligence layer that makes each stage of your transaction defensible.
Detailed, independent intelligence structured to support specific phases of the transaction lifecycle.
Before pursuing any transaction, the strategic case must be stress-tested against market reality. We validate the acquisition rationale by assessing whether the deal actually delivers on its stated strategic objectives.
Validation Framework Metrics
Screening Criteria Scoring
Identifying the right acquisition target requires a structured, intelligence-driven approach. We map the full universe of potential targets against your strategic criteria, score each on fit and attractiveness.
The intelligence backbone of sound M&A. We assess the target's market position, customer relationships, competitive dynamics, and growth assumptions from an independent market perspective.
CDD Coverage Areas
Of Total Deal Value Evaluated
Synergies are often the most overstated element in M&A. We provide independent market intelligence to validate synergy claims and support post-merger integration with customer retention strategies.
Every engagement delivers structured, board-ready intelligence that supports the most consequential strategic decisions.
The intelligence backbone of sound M&A. We assess the target's market position, customer relationships, competitive dynamics, and growth assumptions from an independent market perspective.
Independent go/no-go recommendation based on market reality.
Prioritised shortlist mapped against strict strategic criteria.
Validated estimates with complex probability modelling.
Post-deal sentiment analysis and deep retention risk metrics.
Unlike financial advisors, we provide pure market intelligence — independent of deal economics — ensuring due diligence reflects reality.
We interview actual customers, channel partners, and industry experts — providing first-hand commercial insights.
With 32+ countries covered and cross-border M&A capabilities, we support transactions across all major geographies.
Our analysts bring deep sector knowledge across pharma, tech, FMCG, and industrials — ensuring genuine industry understanding.